Our
Team
Our interdisciplinary team comprises of experts across medicinal chemistry, cheminformatics, computational biology and machine learning
Dr. Francesco Trozzi, PhD, is a part of Harmonic Discovery's computational chemistry team. Dr. Trozzi received his PhD from SMU where he studied the mechanism of protein allostery in LOV Domains and ACE2 PD via molecular dynamics and machine learning.
Dr. Anna Cichońska, PhD, is Harmonic Discovery's Director of Data Science and Head of European Operations. Dr. Cichońska completed her PhD at Aalto University and the Finnish Institute for Molecular Medicine in computational biology and machine learning. She is an expert in the development of machine learning models to predict kinase-ligand interactions.
.png)
Dr. Ravi Rajagopalan, PhD is VP of Drug Discovery & Development at Harmonic Discovery. Dr. Rajagopalan is a biology, drug discovery and development leader with 20 years of collective experience in SF bay area biotechs (Celera Genomics, InterMune and Blade Therapeutics). Ravi has directly contributed to 5 clinical candidates and 3 marketed drugs.
Dr. Marcel Patek, PhD, is a co-founder and CSO of Harmonic Discovery. Dr. Patek is an industry veteran with over 25+ years of experience in drug discovery. Previously he was the Director of Chemistry at Sanofi and the Vice President of chemistry at ICAGEN.
Dr. Navriti Sahni, PhD, is a part of the Medicinal and Computational Chemistry team at Harmonic Discovery. Dr. Sahni completed her PhD at Punjabi University and has extensive expertise in designing multi-targeted kinase therapeutics.
Dr. Guru Ravikumar, PhD, is Harmonic Discovery's Director of Chemical Informatics. Dr. Ravikumar completed his PhD at the University of Helsinki where he developed several computational chemogenomic approaches to study the polypharmacology of kinase inhibitors.
Dr. Rayees Rahman, PhD, is a co-founder and CEO of Harmonic Discovery. Dr. Rahman completed his PhD at the Icahn School of Medicine at Mount Sinai where he developed machine learning approaches to characterize the 3D structure of protein kinases and their inhibitors.
Dr. Jason Lee, MD, is a co-founder and COO of Harmonic Discovery. Dr. Lee completed his medical training at the Icahn School of Medicine at Mount Sinai. Previously he was a life science investor at OrbiMed, and performed business development duties at Pacira Pharmaceuticals.
Ryan Theisen is part of the Machine Learning team at Harmonic Discovery. He completed his PhD in Theoretical Machine Learning at the University of California, Berkeley.
Board of Directors & Scientific Advisory Board
Dr. Andreas Bender is leading expert in medicinal chemistry and cheminformatics. Dr. Bender is a Professor of Molecular Informatics at Cambridge University and CSO of Terra Lumina. Previously he was Associate Director of Computational ADME and Safety at AstraZeneca and at co-founder of HealX.
Dr. Oliver Elemento, PhD, is an expert in biomedical data science and systems biology for drug discovery. Dr. Elemento is a Professor of Physiology and Biophysics at Weill Cornell Medicine and the Director of the Englander Institute for Precision Medicine. He is also the founder of venture-backed startups such as Volastra Therapeutics and Onethree Biotech.
Dr. Omar Abdel-Wahab, MD, is an oncologist and expert in blood and solid tumors. Dr. Abdel Wahab is the Chair of Molecular Pharmacology at the Sloan Kettering Institute and Director, MSK Center for Hematologic Malignancies.
Dr. Tero Aittokallio, PhD, is an expert in statistical and predictive drug response modeling. He is professor and group leader at the Institute for Cancer Research at Oslo University Hospital and a group leader at the Institute for Molecular Medicine Finland.
.png)
Dr. John Mascarenhas is a Professor of Medicine at the Icahn School of Medicine, where he directs the Adult Leukemia Program. He has deep experience in Myeloproliferative neoplasms, specifically in Myelofibrosis.
Dr. Stephen Oh is an Associate Professor of Medicine in the Division of Hematology at Washington University School of Medicine. His research focuses on myeloproliferative neoplasms (MPNs) and his group investigates fundamental mechanisms driving the initiation, development and progression of MPNs.
Dr. Joel Dudley is an expert in biomedical data science, computational biology and machine learning. He currently is a partner at Innovation Endeavors. Previously he was Chief Scientific Officer at Tempus Labs, and executive Vice President and Associate Professor at the Mount Sinai School of Medicine. He was also the co-founder of companies such as Onegevity Health and Numedii.
Harmonic Discovery Student Scientists
.png)
Tran is a PhD student in Biophysics at University of California Irvine
.png)
David Allegakoen is an MD/PhD student at Georgetown University
Harmonic Alumni
Annalise Schweickart is a PhD student at the Tri-Institutional Computational Biology and Medicine Program at Weill Cornell Medical College.
Carmen Al-Masri is a PhD student in Computational Chemistry at University of California Irvine.
Colin Small is a Masters student in Bioinformatics at Brown University.
Dr. Eric Bach, PhD. Completed his PhD at Aalto University in Machine Learning.
Katalina Biondi is a PhD student in Machine Learning the University of Southern Florida.
Yajas Shah is a PhD student in Computational and Systems Biology at Weill Cornell Medical College.
Dr. Yohana Ghebrechristos, PhD completed her PhD in Cancer Biology at New York University.
Jason Lin is a BS student in Chemical Engineering at the University of Michigan Ann Arbor
Dr. Michael Moret, PhD completed his PhD in molecular machine learning at ETH Zurich. He is currently a post-doc at the George Church Lab at Harvard
Steven Pak is a PhD student in computational chemistry at Stony Brook University
.png)
Ankita is a PhD student in computational chemistry at City University of New York
.png)
Ryan Park is an undergraduate student at Stanford University
.png)
Prateek Adurty is an undergraduate student at the University of Pennsylvania
Tian Wang is a PhD student in computational biology at the University of Helsinki and Aalto University,